
Innovation Global
San Francisco, California, United StatesFounded 2013
Innovation Global Capital is a San Francisco-based venture capital firm founded in 2013 that builds disruptive early-stage companies transforming industries through AI, advanced technology, and innovation.
Average disclosed round size is $19.0M (across 21 rounds with reported amounts).
Portfolio
22
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
YK
Yasunobu Kyogoku
Founding Partner
MZ
Mo Z.
Founder
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
25 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Seed | $8.5M | Mar 2025 | |
| Series B | — | Jan 2025 | |
| Series A | — | Jan 2025 | |
| RRege Nephro Co.,Ltd. | Unknown | — | Oct 2024 |
| Unknown | $7M | Jan 2024 | |
| Growth | — | Jan 2022 | |
| TTimeseer | Seed | $6M | Jan 2022 |
| Series C | $56M | Mar 2020 | |
| CChoosy | Seed | $5.4M | May 2018 |
| MMagenta Therapeutics | Series B | $50M | May 2017 |
| Series B | $55M | Jan 2017 | |
| SSyntimmune | Series A | $8M | Jan 2016 |
| Series A | $8M | Sep 2012 | |
| Series A | $30M | — | |
| Series B | $30M | — | |
| Pre-Seed | $4M | — | |
| Seed | $4M | — | |
| RRegeNephro | Unknown | $17M | — |
| Series A | $4.4M | — | |
| LLysosomal Therapeutics Inc. | Series A | $20M | — |
| LLysosomal Therapeutics Inc. | Seed | $4.8M | — |
| TTriplet Therapeutics | Series A | $49M | — |
| KKeros | Series B | $23M | — |
| Seed | $5.6M | — | |
| Unknown | $2.9M | — |
Top Co-Investors
Atlas Venture8 shared
SR One3 shared
Alphabet Inc.3 shared
Global Brain Corporation3 shared
Pfizer Ventures2 shared
The Kraft Group2 shared
Pontifax2 shared
Arkin Bio Ventures2 shared
Tau Ventures2 shared
Gaingels2 shared
Grep VC2 shared
NextGen Venture Partners2 shared
Asahi Kasei2 shared
JAFCO Group Co., Ltd.2 shared
JIC Venture Growth Investments2 shared
Roche Venture Fund2 shared
Omega Funds1 shared
Frazier Healthcare Partners1 shared
The Baupost Group1 shared
Rock Springs Capital1 shared
Last updated: 8 September 2026